Malka Roy, Delgado Francisco Feijó, Manalis Scott R, Higgins John M
Center for Systems Biology and Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Department of Systems Biology, Harvard Medical School, Boston, Massachusetts, United States of America.
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
PLoS Comput Biol. 2014 Oct 9;10(10):e1003839. doi: 10.1371/journal.pcbi.1003839. eCollection 2014 Oct.
Human red blood cells (RBCs) lose ∼30% of their volume and ∼20% of their hemoglobin (Hb) content during their ∼100-day lifespan in the bloodstream. These observations are well-documented, but the mechanisms for these volume and hemoglobin loss events are not clear. RBCs shed hemoglobin-containing vesicles during their life in the circulation, and this process is thought to dominate the changes in the RBC physical characteristics occurring during maturation. We combine theory with single-cell measurements to investigate the impact of vesiculation on the reduction in volume, Hb mass, and membrane. We show that vesicle shedding alone is sufficient to explain membrane losses but not volume or Hb losses. We use dry mass measurements of human RBCs to validate the models and to propose that additional unknown mechanisms control volume and Hb reduction and are responsible for ∼90% of the observed reduction. RBC population characteristics are used in the clinic to monitor and diagnose a wide range of conditions including malnutrition, inflammation, and cancer. Quantitative characterization of cellular maturation processes may help in the early detection of clinical conditions where maturation patterns are altered.
人类红细胞(RBCs)在血液循环中约100天的寿命期间会损失约30%的体积和约20%的血红蛋白(Hb)含量。这些观察结果有充分的文献记载,但这些体积和血红蛋白损失事件的机制尚不清楚。红细胞在循环过程中会释放含血红蛋白的囊泡,这一过程被认为主导了成熟过程中红细胞物理特性的变化。我们将理论与单细胞测量相结合,以研究囊泡形成对体积、血红蛋白质量和膜减少的影响。我们表明,仅囊泡脱落就足以解释膜的损失,但不能解释体积或血红蛋白的损失。我们使用人类红细胞的干质量测量来验证模型,并提出其他未知机制控制体积和血红蛋白的减少,并且是观察到的减少的约90%的原因。红细胞群体特征在临床上用于监测和诊断各种病症,包括营养不良、炎症和癌症。细胞成熟过程的定量表征可能有助于早期发现成熟模式发生改变的临床病症。